Shares of Ambrx Biopharma Inc. (NYSE:AMAM – Get Rating) shot up 6.2% on Tuesday . The company traded as high as $14.96 and last traded at $14.88. 257,564 shares were traded during trading, a decline of 92% from the average session volume of 3,041,147 shares. The stock had previously closed at $14.01. Wall Street Analyst […]
Cantor Fitzgerald started coverage on shares of Ambrx Biopharma (NYSE:AMAM – Get Rating) in a research note issued to investors on Friday, The Fly reports. The brokerage issued an overweight rating and a $25.00 price target on the stock. AMAM has been the subject of a number of other research reports. The Goldman Sachs Group […]
Ambrx Biopharma Inc. (NYSE:AMAM – Get Rating)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $13.20 and last traded at $13.11, with a volume of 1237453 shares trading hands. The stock had previously closed at $12.06. Wall Street Analysts Forecast Growth AMAM has been the topic of […]